Advertisement

Topics

Companies Related to "Study of Chediak-Higashi Syndrome" [Most Relevant Company Matches] RSS

00:52 EST 22nd February 2019 | BioPortfolio

Here are the most relevant search results for "Study of Chediak-Higashi Syndrome" found in our extensive corporate database of over 50,000 company records.

Showing "Study Chediak Higashi Syndrome" Companies 1–25 of 740

Relevant

Research Down Syndrome

Research Down Syndrome (RDS) is a non-profit foundation which funds research at leading institutions directed towards identifying safe and effective biomedical therapies to treat the intellectual difficulties associated with Down syndrome. RDS' mission is to educate and inspire society to fund and support Down syndrome cognitive research to enhance and expand life opportunities, helping people wit...


Sjogren's Syndrome Foundation

Founded in 1983, the Sjogren's Syndrome Foundation (SSF) provides patients with practical information and coping strategies that minimize the effects of Sjogren's syndrome. In addition, the Foundation is the clearinghouse for medical information and is the recognized national advocate for Sjogren's syndrome. The Foundation's mission is to educate patients and their families about Sjogren's syndrom...

Global Down Syndrome Foundation

The Global Down Syndrome Foundation is a public non-profit 501(c)(3) dedicated to significantly improving the lives of people with Down syndrome through research, medical care, education, and advocacy. Formally established in 2009, the Foundation’s primary focus is to support the Linda Crnic Institute for Down Syndrome, the first academic home in the ...


Angelman Syndrome Foundation

Since 1996, the Angelman Syndrome Foundation has funded 59 research grants totaling more than $3.5 million. The Angelman Syndrome Foundation has awarded a majority of these funds ($3.3 million) beginning in 2005. For more information on the Foundation, please visit www.angelman.org.

SOFTFLEX computer gloves

An epidemic of computer-associated hand and wrist pain and numbness now affects 7 million Americans a year. These symptoms are frequently and routinely misdiagnosed as carpal tunnel syndrome when they are, in fact, a result of Computer-Associated Carpal Tunnel Syndrome. The numbness and tingling that signal Computer-Associated Carpal Tunnel Syndrome are caused by pressure placed on the median nerv...

International Rett Syndrome Foundation

Rett syndrome (RTT), a brain disorder affecting development in childhood, has been identified almost exclusively in females. RTT results in severe movement and communication problems following apparently normal development for the first six months of life. The characteristic features include loss of speech and purposeful hand use, occurrence of repetitive hand movements, abnormal walking, abnorm...

Down Syndrome Association of Los Angeles

Who: Down Syndrome Association of Los Angeles (DSALA) with National Down Syndrome Society Buddy Walk® Spokesperson John C. McGinley, Dr. Cox on the ABC’s SCRUBS; Grand Marshal, Dr. Jim Sears of THE DOCTORS; Honoring Ken Jenkins, Dr. Kelso of SCRUBS with the Buddy Award, Emcees Mark Wallengren and Kristin Cruz of KOST’s Morning Show, a live dan...

ConSynance Therapeutics Inc.

ConSynance Therapeutics is a clinical-stage drug development company based in Rensselaer, New York. ConSynance’s pipeline includes innovative treatments for NASH, the orphan disease Prader-Willi syndrome, and irritable bowel syndrome. www.consynance.com

NPS Pharmaceuticals, Inc.

NPS Pharmaceuticals is developing new treatment options for patients with rare gastrointestinal and endocrine disorders. The company is currently advancing two Phase 3 registration programs. Teduglutide, a proprietary analog of GLP-2, is being evaluated as GATTEX® in a Phase 3 registration study known as STEPS for intestinal failure associated with shor...

Foundation for Angelman Syndrome Therapeutics (FAST)

Angelman Syndrome (AS) was first described by Dr. Harry Angelman in 1965. Common symptoms include developmental delay and intellectual disabilities, happy demeanor, movement and balance disorder, severe sleep disorders, seizures and limited speech. Most children are diagnosed between the ages of 3-5 but early detection and intervention can make a significant difference in the child's development ...

Pharmacon Research GmbH

Pharmacon Research is an independent contract research organization (CRO) with headquarters in Berlin and clinical sites in Prague, Warsaw, Bratislava and Budapest. Founded in 1992 by the management of a successful Phase I unit, Pharmacon Research focuses on specific Phase I studies in patients and symptomatic subjects and on early Phase II studies (dose finding, proof of concept). Irrespective of...

The International Rett Syndrome Foundation

While there are over 3,800 known cases of Rett Syndrome in the United States which predominantly strikes only girls, the disorder is genetically linked to more widespread neurological disorders such as autism and schizophrenia. Rett symptoms begin to manifest between the first six to eighteen months of life and in most cases will eventually incapacitate the afflicted children so that they can...

The Finnish Breast Cancer Group

The study, led by the Finnish Breast Cancer Group, was a large open-label, two-arm, randomised multicentre phase III study in women with early breast cancer. 1,500 patients in Finland and Sweden with no distant metastases who had an intermediate to high risk of recurrence within five years from the time of diagnosis, were recruited to the study.

i3 Statprobe

Because we're strong in every area, you can outsource an entire study to i3 Statprobe, or outsource, for example, only the statistical programming for a single study. Or you can outsource only the statistical programming for every study. Use us any way you want to, we encourage it. For example, we'll provide a dedicated team of specialists (say, data coordinators or statistical programmers) to wor...

Probably Relevant

BioClin Therapeutics, Inc.

BioClin Therapeutics, Inc. is a privately-held clinical stage drug development company developing biologics to address medical conditions in areas of high unmet need. The company’s lead candidate is B-701, a potential first-in-class human monoclonal antibody targeting FGFR3 (fibroblast growth factor receptor 3). B-701 is currently being evaluated in t...

PellePharm

Founded by world leaders in hedgehog signaling, PellePharm, a BridgeBio company, is committed to targeting rare genetic dermatological conditions, including Gorlin Syndrome and Basal Cell Carcinomas (BCCs), at the source. PellePharm is committed to improving the quality of life for those suffering from Gorlin Syndrome and BCCs by providing an easy-to-use t...

ConSynance Therapeutics, Inc.

ConSynance Therapeutics is a clinical-stage drug development company based in Rensselaer, New York. The company’s pipeline includes innovative treatments for nonalcoholic steatohepatitis (NASH), the orphan disease Prader-Willi syndrome, and irritable bowel syndrome. ConSynance are collaborating with Chengdu SciMount Pharmatech Co., Ltd., a drug discov...

Catalyst Pharmaceutical Partners, Inc.

Catalyst Pharmaceutical Partners, Inc. is a specialty pharmaceutical company focused on the development and commercialization of prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, including Lambert-Eaton Myasthenic Syndrome (LEMS), infantile spasms, and Tourette Syndrome. In 2012, Catalyst licensed Firdapse from BioMarin, a...

Tyrogenex

Tyrogenex is developing X-82, as a targeted therapeutic for ophthalmological diseases and solid tumors. Preliminary data from a phase 1/2 pilot study show that X-82 is well tolerated and did not exhibit any dose-limiting toxicity during the study.

GlobalCare Clinical Trials, Ltd

GlobalCare Clinical Trials, Ltd, is the leading global provider of ambulant healthcare services for clinical trials to government agencies and the world’s biopharmaceutical and medical device companies engaged in all phases of product development. GlobalCare provides innovative, GCP-compliant services by conducting selected study visits in the home or...

Lexicon Pharmaceuticals, Inc.

Lexicon is a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease. Lexicon currently has four drug candidates in mid-stage development for diabetes, irritable bowel syndrome, carcinoid syndrome and rheumatoid arthritis, all of which were discovered by Lexicon's research team. Lexicon has used its proprietary gene knockout technology to identif...

PharmaLinkFHI, Inc.

PharmaLink provides complete eClinical research services to support and streamline the drug development process. Clinical teams leverage real-time study information to make immediate decisions based on emerging trends and study issues. Our accelerated processes, centralized information management and global reach make it possible to conduct trials of any size or complexity from virtually anywhere....

GlycoMark, Inc.

GlycoMark is an FDA-cleared blood test that reveals repeated episodes of postprandial hyperglycemia/glycemic variability by tracking postprandial glucose levels as they related to blood levels of the molecule 1,5-anhydroglucitol (1,5-AG). Multiple published studies indicate that 1,5-AG detects hyperglycemia not detected by the hemoglobin A1C test. A recent study conducted as part of the internat...

Cypress Bioscience

We are committed to being the innovator and leader in providing products for the treatment of patients with Functional Somatic Syndromes, such as Fibromyalgia Syndrome, or FMS, and other central nervous system disorders. Specifically, our strategy involves acquiring or in-licensing central nervous system, or CNS, active compounds and developing them for novel and typically underserved indications....

Tourette Syndrome Association


More From BioPortfolio on "Study of Chediak-Higashi Syndrome"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks